Longwall Venture Partners is a specialist venture capital firm focused on backing early-stage UK companies operating in the healthcare, science, and engineering sectors.
The seed round was co-led by BGF and Longwall Venture Partners with participation from seed backers including BioCity, Alderley Park Ventures, and Puffin Point.
"This marks a huge step forward for Kinomica and for KScan™, as we look to the future of cancer treatment. Our pioneering technology offers much-needed support for the development of new precision medicines and represents a new approach to drug trials and treatments that will have a huge impact on patients’ lives."
The seed round was led by UKI2S and Longwall Ventures to support cell therapy bioprocessing development.
"We are thrilled to close this initial funding round with help from UKI2S. We are continuing to establish partnerships with Biotech and Pharma, on top of our existing partnerships with the Cell and Gene Therapy Catapult and the Centre for Process Innovation. The funding will be used to further develop our technology, as well as fund trials with our partners."
The funding round was led by Longwall Venture Partners to support research and technology scaling.
"This investment gives us a platform to really accelerate in 2020 and scale-up the delivery of our game-changing technology to farmers across the country. We’re seeing rising demand from around the world for new technologies to help farmers grow crops in ways that mitigate against the effects of climate change and ever-increasing extreme weather events."
Longwall Ventures and the Angel CoFund led the Series A round to support the development of advanced metal 3D printing systems.
"Additive Manufacturing is currently one of the fastest growing, disruptive technology spaces, providing manufacturers with the ability to produce high value components that would have been impossible even ten years ago. We are excited to be developing our new product in such a high-potential market, and look forward to driving its rapid growth as we prepare to launch in the coming years."
The financing round was backed by IQ Capital, Longwall Venture Partners, Martlet, and Cambridge Angels.
"Having been in stealth mode for several years, this latest fund raising marks a significant milestone for the business and its founders. As well as securing venture capital funding from experienced investors in deep tech and life sciences, we have been able to establish corporate partnerships with international Pharma companies and the NHS, we have also hired a senior management team that represents the very best in talent across healthcare and technology."
